Author

N. Chakravarty

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1 Assay:metabolomics· 1

Frequent Co-Authors

A. Ramaiah· 2 shared A. Shah· 2 shared S. Dubey· 2 shared V. Arumugaswami· 2 shared A. Deb· 1 shared A. Fanaei· 1 shared A. L. Marquez· 1 shared A. P. Huang· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

A. Ramaiah

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Comparative Analysis of Molecular Pathogenic Mechanisms and Antiviral Development Targeting Old and New World Hantaviruses

A. V. Jeyachandran, J. I. Irudayam, S. Dubey, N. Chakravarty, B. Konda, A. Shah, B. Su, C. Wang, Q. Cui, K. J. Williams, S. Srikanth, Y. Shi, A. Deb, R. Damoiseaux, B. Stripp, , V. Arumugaswami

This study compares molecular mechanisms and antiviral targets of Old and New World hantaviruses using human cell models and identifies potential therapeutic compounds.

bioRxiv · Aug 4, 2023 · PreprintMicrobiology

Broad-spectrum antiviral inhibitors targeting pandemic potential RNA viruses

G. Garcia, J. Ignatius Irudayam, A. Vijay Jeyachandran, S. Dubey, C. Chang, S. Castillo Cario, N. Price, S. Arumugam, A. L. Marquez, A. Shah, A. Fanaei, N. Chakravarty, S. Joshi, S. Sinha, S. W. French, , V. Arumugaswami

This study identifies broad-spectrum antiviral agents effective against multiple RNA virus families, including arboviruses and respiratory pathogens.

bioRxiv · Jan 19, 2023Microbiology

Comparing Expression of OAS-RNaseL Pathway-Related Genes in SARS-CoV-2 and Similar Viruses

N. Chakravarty, P. A. Edillor, A. P. Huang, G. A. Torres, M. T. Usmani, P. Kadandale

This study analyzes the OAS-RNaseL pathway gene expression in response to SARS-CoV-2 and similar viruses using transcriptomic data, finding cell-type-dependent upregulation and similarities across coronaviruses.

bioRxiv · Apr 29, 2021 · PreprintImmunology